Henrik S MD Rasmussen's Net Worth
$14.1 Million
Who is Henrik S MD Rasmussen?
Henrik S MD Rasmussen has an estimated net worth of $14.1 Million. This is based on reported shares across multiple companies, which include ZS Pharma, Inc., Allakos Inc., and NABI BIOPHARMACEUTICALS.
SEC CIK
Henrik S MD Rasmussen's CIK is 0001271905
Past Insider Trading and Trends
2021 was Henrik S MD Rasmussen's most active year for acquiring shares with 6 total transactions. Henrik S MD Rasmussen's most active month to acquire stocks was the month of April. 2021 was Henrik S MD Rasmussen's most active year for disposing of shares, totalling 16 transactions. Henrik S MD Rasmussen's most active month to dispose stocks was the month of November. 2015 saw Henrik S MD Rasmussen paying a total of $937,743.75 for 19,875 shares, this is the most they've acquired in one year. In 2021 Henrik S MD Rasmussen cashed out on 226,537 shares for a total of $13,355,966.08, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ZS Pharma, Inc. No price found
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -3.00K |
$90.00 | -$270,000.00 |
0
|
Dec 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Allakos Inc. (ALLK) Snapshot price: $1.28
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.61% | -3.27K |
$90.90 | -$295,070.80 | 199.53K |
Scheduled
|
Jun 3 - Jun 4
| ||
Form 4
|
—
|
0
|
$56.93 | -$5,607,875.00 | 233.64K |
Scheduled
|
Apr 1 - Apr 6
| ||
Form 4
| -0.71% | -3.27K |
$58.41 | -$7,325,145.28 | 454.45K |
Scheduled
|
Mar 1 - Mar 3
| ||
Form 4
| +85.62% | 48.35K |
$99.04 | -$391,604.16 | 104.81K |
Dec 1 - Dec 2
| |||
Form 4
| +1,883.33% | 52.3K |
—
|
—
| 55.08K |
Nov 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NABI BIOPHARMACEUTICALS (VXRT) Snapshot price: $1.19
Sr. VP Clin. Med. & Reg. Affs.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +4.43% | 3.57K |
$2.73 | $9,750.00 | 84.26K |
May 31
| |||
Form 4
| +98.31% | 40K |
—
|
—
| 80.69K |
May 12
| |||
Form 4
| +1,337.75% | 37.86K |
—
|
—
| 40.69K |
Feb 24
| |||
Form 4
| +96.47% | 921.33 |
$10.58 | $9,750.00 | 1.88K |
May 31
| |||
Form 4
| +135.09% | 548.78 |
$12.30 | $6,750.00 | 955.02 |
Nov 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 11
| |||
Form 4
|
∞
| 406.24 |
$9.23 | $3,750.00 | 406.24 |
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 24
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||